Founded in mid-2008 with the intent of developing novel and life-changing therapies for patients with solid tumors and backed by a consortium of private investors composed of experienced scientists and entrepreneurs, Stem CentRx is using its proprietary discovery platforms to yield unprecedented insight into the biology of solid tumors. This insight is being exploited in efforts to develop potent new therapies for cancer.

Thank you for your interest and keep tuned to this website for more news.